ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesF13.180

F13.180

Billable

Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced anxiety disorder

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 F13.180 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced anxiety disorder.

Key Diagnostic Point:

F13.180 refers to a condition characterized by the abuse of sedative, hypnotic, or anxiolytic substances, leading to the development of an anxiety disorder induced by these substances. Patients may misuse medications such as benzodiazepines or barbiturates, often to alleviate anxiety or insomnia. However, prolonged use can result in tolerance, dependence, and withdrawal symptoms, which may exacerbate anxiety levels. Clinically, individuals may present with heightened anxiety, panic attacks, or other anxiety-related symptoms that are directly linked to their substance use. Treatment typically involves a combination of detoxification, psychotherapy, and possibly the use of alternative medications to manage anxiety symptoms. It is crucial for healthcare providers to recognize the dual diagnosis of substance abuse and anxiety disorder to tailor effective treatment plans.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Dual diagnosis requiring careful assessment of both substance use and anxiety symptoms.
  • Need for comprehensive documentation to support the diagnosis and treatment plan.
  • Potential for overlapping symptoms with other mental health disorders.
  • Variability in patient presentation and response to treatment.

Audit Risk Factors

  • Inadequate documentation of substance use history.
  • Failure to document the relationship between substance use and anxiety symptoms.
  • Misclassification of anxiety symptoms as primary rather than substance-induced.
  • Lack of evidence for treatment plans addressing both conditions.

Specialty Focus

Medical Specialties

Psychiatry

Documentation Requirements

Detailed patient history, including substance use patterns and mental health evaluations.

Common Clinical Scenarios

Patients presenting with anxiety symptoms who have a history of sedative use.

Billing Considerations

Ensure clear differentiation between primary anxiety disorders and those induced by substance use.

Addiction Medicine

Documentation Requirements

Comprehensive assessment of substance use, including frequency, duration, and impact on daily functioning.

Common Clinical Scenarios

Patients undergoing detoxification who exhibit anxiety symptoms.

Billing Considerations

Focus on the interplay between substance withdrawal and anxiety management.

Coding Guidelines

Inclusion Criteria

Use F13.180 When
  • According to ICD
  • 10 coding guidelines, F13
  • 180 should be used when there is clear evidence of sedative, hypnotic, or anxiolytic abuse leading to an anxiety disorder
  • Documentation must support the diagnosis, including the timeline of substance use and the onset of anxiety symptoms

Exclusion Criteria

Do NOT use F13.180 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

99214CPT Code

Established patient office visit, level 4

Clinical Scenario

Used for follow-up visits in patients with substance use and anxiety disorders.

Documentation Requirements

Document the patient's history, current symptoms, and treatment plan.

Specialty Considerations

Psychiatrists may need to provide detailed notes on the patient's substance use history.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more precise coding of substance use disorders, including the differentiation of conditions like F13.180, which aids in better treatment planning and resource allocation.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more precise coding of substance use disorders, including the differentiation of conditions like F13.180, which aids in better treatment planning and resource allocation.

Reimbursement & Billing Impact

impact on mental health. Treatment plans should be clearly outlined to justify the use of this code.

Resources

Clinical References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Coding & Billing References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Frequently Asked Questions

What is the difference between F13.180 and F13.10?

F13.180 includes the presence of an anxiety disorder induced by substance abuse, while F13.10 refers to dependence without the anxiety component.